Found 15 matching trials
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease
PHASE1This study is being conducted to determine the safety, tolerability, and ph...
Location
Pacific Research Network, Inc.
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
PHASE2The purpose of this study is to evaluate the safety of 2 fixed doses of EVP...
Location
Multiple Locations
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
PHASE3The purpose of this study is to evaluate the safety and efficacy of 2 fixed...
Location
Multiple Locations
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia
PHASE1This study in patients with schizophrenia is designed to provide preliminar...
Location
Clinical Research Institute
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
PHASE3The purpose of this study is to determine if EVP-6124 (an alpha-7 nAChR ago...
Location
Multiple Locations
Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects
PHASE1The purpose of this study is to evaluate the effect of EVP-6124 at therapeu...
Location
Multiple Locations
Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia
PHASE2This study is being conducted to determine the safety and effect on cogniti...
Location
Intergrated Medical and Behavioral Associates
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
PHASE3The purpose of this study is to determine if EVP-6124 (an alpha-7 nAChR ago...
Location
Multiple Locations
A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence
PHASE2This study is designed to evaluate the initial evidence for efficacy of the...
Location
Massachusetts General Hospital
Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
PHASE2This study is being conducted to determine the safety and effect on cogniti...
Location
HOPE Research Institute